Loading clinical trials...
Loading clinical trials...
This study is a drug use investigation program of NUCALA. The objective of this study is to collect and assess information on the safety and effectiveness of the long-term use of NUCALA SC injection i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
GlaxoSmithKline
NCT02593565 · Vasculitis, Behcet's Disease, and more
NCT03004326 · Cryoglobulinemic Vasculitis (CV), Drug-induced Vasculitis, and more
NCT01241305 · Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis, and more
NCT05979051 · Eosinophilic Granulomatosis With Polyangiitis
NCT06046222 · Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome
GSK Investigational Site
Tokyo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions